MedDataX Logo

Application of Magnetic Fields as Adjunctive Treatment for Type II Diabetes

NCT ID: NCT00863954

Last Updated: 2010-12-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-01-31

Study Completion Date

2009-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to see if using a device called the Resonator, that puts out a very low electromagnetic field, effects blood glucose and A1c levels in people with Type 2 Diabetes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this pilot study is to determine whether application of magnetic fields generated by the Resonator result in statistically significant reductions in finger stick blood glucose levels, serum glucose and hemoglobin A1c levels. The study will also investigate any induced changes in serum lipids and liver function tests as indirect markers of insulin resistance.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Type II Diabetes Mellitus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Output A

Group Type ACTIVE_COMPARATOR

Resonator Device

Intervention Type DEVICE

comparison of different parameter settings of electromagnetic fields using the Resonator Device

Output B

Group Type ACTIVE_COMPARATOR

Resonator Device

Intervention Type DEVICE

comparison of different parameter settings of electromagnetic fields using the Resonator Device

Output C

Group Type ACTIVE_COMPARATOR

Resonator Device

Intervention Type DEVICE

comparison of different parameter settings of electromagnetic fields using the Resonator Device

Output D

Group Type ACTIVE_COMPARATOR

Resonator Device

Intervention Type DEVICE

comparison of different parameter settings of electromagnetic fields using the Resonator Device

Output E

Group Type ACTIVE_COMPARATOR

Resonator Device

Intervention Type DEVICE

comparison of different parameter settings of electromagnetic fields using the Resonator Device

Output F

Group Type ACTIVE_COMPARATOR

Resonator Device

Intervention Type DEVICE

comparison of different parameter settings of electromagnetic fields using the Resonator Device

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Resonator Device

comparison of different parameter settings of electromagnetic fields using the Resonator Device

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Current diagnosis of Type II Diabetes Mellitus with A1c level above the upper limit of normal
* Subject currently performs routine finger stick blood sugar testing
* Subject is ambulatory
* None or stable medication regimen without significant side effects for at least 6 months, willingness and ability to maintain the stable medication regimen throughout the course of the study.
* Hemoglobin A1c levels within a 0.8% range of patient mean A1c level for the last two documented determinations, that must be within 2 years of the baseline testing date.
* Willingness to test finger stick blood sugars according to protocol.
* Willingness to have lab test blood draws performed according to protocol
* Willingness to maintain stable diet and activity regimen for the duration of the study.
* Willing and able to abstain from partaking in any non-essential existing or new treatments to improve serum blood sugar levels.
* Adequate contraceptive measures for female subjects
* Male or female
* Any ethnic group
* Between 21 and 80 years of age

Exclusion Criteria

* Change in medical regimen within 6 months prior to initiation of study
* Any signs of Type I diabetes
* Active infectious process within 3 weeks of study initiation causing wide fluctuations in finger stick blood sugar level.
* Change in BMI of greater than 6% within a 6 month period prior to study initiation
* Any planned revascularization procedure
* Symptomatic congestive heart failure
* Leg or foot ulceration or open wounds
* Gangrene
* History of intermittent claudication
* Hemodialysis
* Currently being treated for malignancy
* Currently being treated with oral or intravenous catabolic steroids.
* Reported consumption of more than 14 alcoholic drinks per week.
* Pregnant, breast feeding,or planning pregnancy prior to the end of participation.
* Developmental disability or cognitive impairment that would make it difficult for the subject to partake in the clinical study, including adequate comprehension of the informed consent form and ability to record the necessary measurements.
* Uncontrolled hypertension
* Uncontrolled atrial fibrillation or other uncontrolled arrythmias, e.g. tachycardia, bradycardia
* Uncontrolled seizure disorder
* Uncontrolled, unstable, or untreated medical conditions which may significantly impact the subjects health or ability to complete the entire study, in the opinion of the investigator
Minimum Eligible Age

21 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

pico-tesla Magnetic Therapies, LLC

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

pico-tesla Magnetic Therapies, LLC

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

pico-tesla Magnetic Therapies

Littleton, Colorado, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

08165-01

Identifier Type: -

Identifier Source: org_study_id